Discover Tenders by Ash Residues Containing Metals Sector

Find the most relevant tenders for Ash Residues Containing Metals. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Ash Residues Containing Metals tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Ash Residues Containing Metals tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Fingolimod Atc Code According To Who L04Ae01

Deadline: 30 Sep 2026

Germany

Ref. No.: 7197234

EMD:Ref Document

Bid Value: Ref Document

355 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Abatacept Atc L04Aa24 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7196201

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lidocaine Atc N01Bb02 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7195634

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ranibizumab Atc S01La04 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7192749

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Naproxen Excluding The Syrup Dosage Form Atc Code According To Who M01Ae

Deadline: 31 Aug 2026

Germany

Ref. No.: 7191964

EMD:Ref Document

Bid Value: Ref Document

325 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tacrolimus Atc L04Ad02 Obo For The Period 01 09 2024 31 08 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2026

Germany

Ref. No.: 7191811

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olopatadine Atc S01Gx09 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7190250

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Febuxostat Atc Code According To Who M04Aa03

Deadline: 30 Sep 2026

Germany

Ref. No.: 7189556

EMD:Ref Document

Bid Value: Ref Document

355 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Chlorthalidone Atc C03Ba04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7189539

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Milnacipran Atc N06Ax17 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7175295

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 31 Aug 2026

Germany

Ref. No.: 7169020

EMD:Ref Document

Bid Value: Ref Document

325 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

268 Days Left

Open House Original Rebate Agreements 2024 06 Aclidinium Bromide Formoterol Active Ingredient Combination

Deadline: 31 Aug 2026

Germany

Ref. No.: 7154440

EMD:Ref Document

Bid Value: Ref Document

325 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Dexamethasone Atc Code H02Ab02 That Can Be Prescribed And Dispensed As Part Of The Consultation Hou

Deadline: 27 Jun 2026

Germany

Ref. No.: 7146194

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Showing 24946 to 24960 of 25110 results

‹
1
2
...
1661
1662
1663
1664
1665
1666
1667
...
1673
1674
›

Discover Tenders by Ash Residues Containing Metals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Ash Residues Containing Metals Sector

Filter Your Search

FREE Trial plan for all new users!